AI-generated summary
The authors systematically reviewed 34 preclinical and clinical articles on ablative fractional lasers used to enhance topical drug uptake into skin. All 16 preclinical studies showed increased drug uptake after laser treatment, and the strongest clinical evidence came from five randomized trials of actinic keratoses treated with photodynamic therapy. The authors report that laser-assisted delivery was beneficial for certain skin conditions, though systemic absorption risks were noted.
- Studies included
- 34
- Who or what was studied
- Preclinical studies and clinical trials of ablative fractional laser-assisted topical drug delivery, including patients with neoplastic lesions, photodamaged skin, scars, onychomycosis, and topical anesthetic use
- Limits stated in the abstract
- The abstract does not report a total number of participants and notes that systemic drug absorption risks exist, particularly over large skin areas.
Written by an AI model from this paper’s abstract only and checked automatically against it, but it can still be wrong. It is not medical advice. Read the full paper. See the editorial policy.
Abstract
The full abstract is not shown here because it is protected by the publisher’s copyright. Read it on linkinghub.elsevier.com.
Record from PubMed, a service of the National Library of Medicine.
How to read a review: what to check before relying on this kind of research.
Terms in this paper: Laser, Photodynamic therapy. Each links to its definition in the glossary.
A summary of published research, not medical advice. One study rarely settles a question. See the disclaimer and how to read research.